Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its
Bioabsorbable Therapeutics, Inc. develops and commercializes medical devices for treating coronary and peripheral vascular diseases. Its products include Whisper coronary stent system, a balloon-expandable fully absorbable coronary stent; and Unison Peripheral Stent System, a self-expanding fully absorbable peripheral stent. The company uses anti-inflammatory polymers to develop bioabsorbable coatings and stents. Bioabsorbable Therapeutics, Inc. was founded in 2004 and is based in Menlo Park, California.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
May 9, 2007 | Series B | $9M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Teton Capital Advisers | — | Series B |
ITX International Holdings | — | Series B |